Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue
- 1 November 1989
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 161 (5) , 1216-1218
- https://doi.org/10.1016/0002-9378(89)90669-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomataEuropean Journal of Cancer and Clinical Oncology, 1989
- Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancerBMJ, 1988
- Gonadotropin-Releasing Hormone as a Modulator of Ovarian FunctionJournal of Steroid Biochemistry, 1985
- Antigonadotropic Actions of GnRH Agonist on Ovarian Cells in vivo and in vitroJournal of Steroid Biochemistry, 1985
- Fetal leydig cess culture—An in vitro system for the study of trophic hormne and GnRH receptors and actionsJournal of Steroid Biochemistry, 1985
- Gonadotropin-releasing hormone as a paracrine hormone and neurotransmitter in extra-pituitary sitesJournal of Steroid Biochemistry, 1985
- Specific Binding of Gonadotrophin-Releasing Hormone and an Agonist to Human Corpus Luteum Homogenates: Characterization, Properties, and Luteal Phase Levels*Journal of Clinical Endocrinology & Metabolism, 1985
- Regarding Research Conducted at the Van LeeuwenhoekhuisNew England Journal of Medicine, 1984
- Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormonesProceedings of the National Academy of Sciences, 1983
- TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1982